Retatrutide Phase 2 Obesity Trial Investigators
Proven Benefits of GLP-1 Receptor Agonists The mechanism by which GLP-1 receptor agonists such as Ozempic and Wegovy work, as described above, facilitates the following benefits: Blood Sugar Control GLP-1 receptor agonists, like Ozempic , effectively lower blood sugar by enhancing insulin sensitivity, boosting insulin release, and decreasing liver glucose production
The Retatrutide peptide 30mg dosage printed on the vial identifies only the quantity of lyophilized peptide supplied and is not a dosing recommendation
"Triple-Hormone-Receptor Agonist Retatrutide for Obesity." NEJM
Prescribing authority was relatively concentrated, and decision-making followed established clinical algorithms
Glucagon-Like Peptide 1 Induces Natriuresis in Healthy Subjects and in Insulin-Resistant Obese Men